In conclusion, we have proved that bezafibrate, an agonist of pan-PPAR, can significantly enhance the proliferation inhibition and apoptosis promotion of GSK126, a selective inhibitor of EZH2, on PC cells in vivo and in vitro. The gene discussed is EZH2; the disease is pachyonychia congenita.